John F. Paolini
2018
In 2018, John F. Paolini earned a total compensation of $2.5M as Senior Vice President and Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd., a 221% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $207,900 |
|---|---|
| Option Awards | $1,875,468 |
| Salary | $409,626 |
| Other | $11,000 |
| Total | $2,503,994 |
Paolini received $1.9M in option awards, accounting for 75% of the total pay in 2018.
Paolini also received $207.9K in non-equity incentive plan, $409.6K in salary and $11K in other compensation.
Rankings
In 2018, John F. Paolini's compensation ranked 4,666th out of 14,244 executives tracked by ExecPay. In other words, Paolini earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,666 out of 14,244 | 67th |
Division Manufacturing | 1,755 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 632 out of 2,122 | 70th |
Industry group Drugs | 530 out of 1,811 | 71st |
Industry Pharmaceutical Preparations | 410 out of 1,385 | 70th |
Source: SEC filing on April 17, 2019.
Paolini's colleagues
We found two more compensation records of executives who worked with John F. Paolini at Kiniksa Pharmaceuticals, Ltd. in 2018.